Berlin Cures’ BC 007 Targeting Long COVID Achieves Solid Progress with Over 50% Patient Recruitment in Phase II Trial
Berlin Cures, a clinical-stage biotechnology firm, advances innovative treatment aimed at combating Long COVID, currently…
Berlin Cures, a clinical-stage biotechnology firm, advances innovative treatment aimed at combating Long COVID, currently…
SINGAPORE--(BUSINESS WIRE)--Sea Limited (NYSE: SE) (“Sea†or the “Companyâ€) today announced its financial results for…
ST. HELIER, Jersey--(BUSINESS WIRE)--Metals Acquisition Limited ARBN 671 963 198 (NYSE: MTAL; ASX: MAC) Metals…
TOKYO--(BUSINESS WIRE)--#ESG--The Ethisphere Institute, a leading US think-tank, has named Kao Corporation (TOKYO:4452) one of…
Celebrating our 25 years by introducing the “5N Proposition†to provide customers with comprehensive long-term…
SHENZHEN, China--(BUSINESS WIRE)--#Hytera--Hytera Communications (SZSE: 002583), a leading global provider of professional communications technologies and…
KUALA LUMPUR, MALAYSIA - Media OutReach Newswire - 4 March 2024 - Human papillomavirus (HPV)…
Berlin Cures, a clinical-stage biotechnology firm, advances innovative treatment aimed at combating Long COVID, currently…
Leading the Two Golden Tracks of Pneumonia Vaccine and Rabies Vaccines HONG KONG SAR -…
KAOHSIUNG, TAIWAN - Media OutReach Newswire - 4 March 2024 - Headed by Deputy Mayor…